Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | RXRA | P19793 | 1/20 | 0.55 |
| ▸ | RXRB | P28702 | 1/20 | 0.55 |
| ▸ | TSPO | P30536 | 1/20 | 0.51 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19986208 | 1.00 | GPR3 (0.61) | GPR3KDM4EHSD17B10HPGDALDH1A1 | |
| SCHEMBL6724269 | 1.00 | GPR3 (0.61) | GPR3KDM4EHSD17B10HPGDALDH1A1 | |
| SCHEMBL883712 | 1.00 | GPR3 (0.61) | GPR3KDM4EHSD17B10HPGDALDH1A1 | |
| SCHEMBL6723905 | 0.96 | GPR3 (0.57) | GPR3KDM4EHSD17B10HPGDALDH1A1 | |
| SCHEMBL17809439 | 0.96 | GPR3 (0.67) | GPR3KDM4EHSD17B10HPGDALDH1A1 | |
| SCHEMBL20842551 | 0.95 | RXRA (0.62) | GPR3KDM4EHSD17B10HPGDALDH1A1 | |
| SCHEMBL19986206 | 0.95 | RXRA (0.62) | GPR3KDM4EHSD17B10HPGDALDH1A1 | |
| SCHEMBL22192128 | 0.95 | RXRA (0.62) | GPR3KDM4EHSD17B10HPGDALDH1A1 | |
| SCHEMBL6724023 | 0.94 | GPR3 (0.50) | GPR3KDM4EHSD17B10HPGDALDH1A1 | |
| SCHEMBL6724002 | 0.94 | GPR3 (0.50) | GPR3KDM4EHSD17B10HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329097-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO LTD (KR) | 2023-10-12 | — | — | US | disclosed |
| US-11706975-B2 | Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display apparatus | SAMSUNG SDI CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-20180083202-A1 | COMPOUND FOR ORGANIC OPTOELECTRIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11706975-B2 | Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display apparatus | OXER1, OCIAD1, OR10J3 | GPR3 1490/4885KDM4E 4115/4885HSD17B10 1066/4885 |
| US-20230329097-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OR10J3, OCIAD2, OCIAD1 | GPR3 1439/4885KDM4E 4500/4885HSD17B10 1380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.